Jeong Hae-min, head of the NHIS Pharmaceutical Management Office, is briefing with the Korea Special Press Association on the 23rd. In the PVA negotiations that reflect this year's revised guidelines, all domestic pharmaceutical companies agreed with the NHIS. Initially, negotiations with some domestic pharmaceutical companies were expected to be difficult due to opposition to the retroactive application of the revised guidelines, but they reached an agreement within the target deadline. The agreed items will be reviewed by the Health Insurance Policy Review Committee this week and announced on September 1. Jeong Hae-min, head of the NHIS Pharmaceutical Management Office, explained in a briefing with the Korea Special